Ginkgo Biloba Extract for Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
A double-blind, randomized, placebo-controlled trial of ginkgo biloba extract (Egb-761) as an add-on therapy to risperidone compared to risperidone plus placebo in the treatment of 200 treatment-naive first-episode patients with schizophrenia. The study addresses an immune dysfunction hypothesis of schizophrenia.
Epistemonikos ID: 13bd365d73c17041406ba149b2b008a7c5b16965
First added on: May 10, 2024